<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32902860</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-1331</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month></PubDate></JournalIssue><Title>European journal of neurology</Title><ISOAbbreviation>Eur J Neurol</ISOAbbreviation></Journal><ArticleTitle>Cortical inexcitability defines an adverse clinical profile in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>90</StartPage><EndPage>97</EndPage><MedlinePgn>90-97</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ene.14515</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE">In amyotrophic lateral sclerosis, studies using threshold-tracking transcranial magnetic stimulation (TMS) have identified corticomotoneuronal dysfunction as a key pathogenic mechanism. Some patients, however, display no motor response at maximal TMS intensities, termed here an 'inexcitable' motor cortex. The extent to which this cortical difference impacts clinical outcomes remains unclear. The aim of this study was to determine the clinical profile of patients with inexcitability to TMS.</AbstractText><AbstractText Label="METHODS">Motor cortex excitability was evaluated using TMS. Patients in whom a motor evoked potential could not be recorded in one or more limbs at maximal TMS intensities were classified as four-limb or partially inexcitable. Demographic information, clinical variables and survival data were analysed.</AbstractText><AbstractText Label="RESULTS">From 133 patients, 40 were identified with inexcitability. Patients with four-limb inexcitability were younger (P&#xa0;=&#xa0;0.03) and had lower-limb disease onset (64%), greater functional disability (P&#xa0;&lt;&#xa0;0.001) and faster disease progression (P&#xa0;=&#xa0;0.02), particularly if inexcitability developed within 1&#xa0;year of symptoms (P&#xa0;&lt;&#xa0;0.01). Patients with partial inexcitability had higher resting motor thresholds compared to the excitable cohort (P&#xa0;&lt;&#xa0;0.01), but averaged short-interval intracortical inhibition was similar (P&#xa0;=&#xa0;0.5). Mean survival was reduced if inexcitability involved all limbs within 12&#xa0;months of symptom onset (P&#xa0;=&#xa0;0.04).</AbstractText><AbstractText Label="CONCLUSION">Amyotrophic lateral sclerosis patients with inexcitability of all four limbs to TMS have a distinct clinical profile of younger age and lower-limb onset. Importantly, these patients display a more malignant disease trajectory, with faster progression, greater functional disability and reduced survival when occurring in early disease. This measure may provide an important prognostic marker in amyotrophic lateral sclerosis.</AbstractText><CopyrightInformation>&#xa9; 2020 The Authors. European Journal of Neurology published by John Wiley &amp; Sons Ltd on behalf of European Academy of Neurology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dharmadasa</LastName><ForeName>T</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-6544-1091</Identifier><AffiliationInfo><Affiliation>Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howells</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matamala</LastName><ForeName>J M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simon</LastName><ForeName>N G</ForeName><Initials>NG</Initials><AffiliationInfo><Affiliation>St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burke</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Sydney Medical School, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vucic</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Westmead Clinical School, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiernan</LastName><ForeName>M C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Neurol</MedlineTA><NlmUniqueID>9506311</NlmUniqueID><ISSNLinking>1351-5101</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019054" MajorTopicYN="N">Evoked Potentials, Motor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035002" MajorTopicYN="N">Lower Extremity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009044" MajorTopicYN="Y">Motor Cortex</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050781" MajorTopicYN="N">Transcranial Magnetic Stimulation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">cortical inexcitability</Keyword><Keyword MajorTopicYN="N">disease progression</Keyword><Keyword MajorTopicYN="N">survival</Keyword></KeywordList><CoiStatement>The authors declare no financial or other conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>9</Day><Hour>12</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32902860</ArticleId><ArticleId IdType="pmc">PMC7820947</ArticleId><ArticleId IdType="doi">10.1111/ene.14515</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vucic S, Kiernan M. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease. Brain 2006; 129: 2436&#x2013;2446.</Citation><ArticleIdList><ArticleId IdType="pubmed">16835248</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibuya K, Park S, Geevasinga N, et al Motor cortical function determines prognosis in sporadic ALS. Neurology 2016; 87: 513&#x2013;520.</Citation><ArticleIdList><ArticleId IdType="pubmed">27402895</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossini P, Burke D, Chen R, et al Non&#x2010;invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: basic principles and procedures for routine clinical and research application. An updated report from an I.F.C.N. Committee. Clin Neurophysiol 2015; 126: 1071&#x2013;1107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6350257</ArticleId><ArticleId IdType="pubmed">25797650</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills K, Nithi K. Corticomotor threshold is reduced in early sporadic amyotrophic lateral sclerosis. Muscle Nerve 1997; 20: 1137&#x2013;1141.</Citation><ArticleIdList><ArticleId IdType="pubmed">9270669</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Ziemann U, Eisen A, Hallett M, Kiernan MC. Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights. J Neurol Neurosurg Psychiatry 2013; 84: 1161&#x2013;1170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3786661</ArticleId><ArticleId IdType="pubmed">23264687</ArticleId></ArticleIdList></Reference><Reference><Citation>Kesar T, Stinear J, Wolf SL. The use of transcranial magnetic stimulation to evaluate the cortical excitability of lower limb musculature: challenges and opportunities. Restor Neurol Neurosci 2018; 36: 333&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6106786</ArticleId><ArticleId IdType="pubmed">29758954</ArticleId></ArticleIdList></Reference><Reference><Citation>Terao Y, Ugawa Y, Sakai K, Uesaka Y, Kohara N, Kanazawa I. Transcranial stimulation of the leg area of the motor cortex in humans. Acta Neurol Scand 1994; 89: 378&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pubmed">8085437</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills K. Magnetic stimulation of the human nervous system. Oxford, UK: Oxford University Press, 1999.</Citation></Reference><Reference><Citation>Dharmadasa T, Matamala J, Howells J, Simon NG, Vucic S, Kiernan MC. The effect of coil type and limb dominance in the assessment of lower&#x2010;limb motor cortex excitability using TMS. Neurosci Lett 2019; 23: 84&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">30710665</ArticleId></ArticleIdList></Reference><Reference><Citation>Dharmadasa T, Matamala J, Howells J, Vucic S, Kiernan MC. Early focality and spread of cortical dysfunction in amyotrophic lateral sclerosis: a regional study across the motor cortices. Clin Neurophysiol 2020; 131(4): 958&#x2013;966.</Citation><ArticleIdList><ArticleId IdType="pubmed">31959568</ArticleId></ArticleIdList></Reference><Reference><Citation>Groppa S, Oliviero A, Eisen A, et al A practical guide to diagnostic transcranial magnetic stimulation: report of an I.F.C.N. Committee. Clin Neurophysiol 2012; 123: 858&#x2013;882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4890546</ArticleId><ArticleId IdType="pubmed">22349304</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Howells J, Trevillion L, Kiernan MC. Assessment of cortical excitability using threshold&#x2010;tracking techniques. Muscle Nerve 2006; 33: 477&#x2013;486.</Citation><ArticleIdList><ArticleId IdType="pubmed">16315324</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher R, Nakamura Y, Bestmann S, Rothwell JC, Bostock H. Two phases of intracortical inhibition revealed by transcranial magnetic threshold tracking. Exp Brain Res 2002; 143: 240&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pubmed">11880900</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon P, Kiernan M, Vucic S. Cortical excitability varies across different muscles. J Neurophysiol 2018; 120: 1397&#x2013;1403.</Citation><ArticleIdList><ArticleId IdType="pubmed">29975162</ArticleId></ArticleIdList></Reference><Reference><Citation>Claus D. Central motor conduction: method and normal results. Muscle Nerve 1990; 13: 1125&#x2013;1132.</Citation><ArticleIdList><ArticleId IdType="pubmed">2266986</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M, Cagnin A, Turkheimer FE, et al Evidence of wide&#x2010;spread cerebral microglial activation in amyotrophic lateral sclerosis. Neurobiol Dis 2004; 15: 601&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pubmed">15056468</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum J, Stambler N, Malta Errol, et al The ALSFRS&#x2010;R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999; 169: 13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Labra J, Menon P, Byth K, Morrison S, Vucic S. Rate of disease progression: a prognostic biomarker in ALS. J Neurol Neurosurg Psychiatry 2016; 87(6): 628&#x2013;632.</Citation><ArticleIdList><ArticleId IdType="pubmed">26152368</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura F, Fujimura C, Ishida S, et al Progression rate of ALSFRS&#x2010;R at time of diagnosis predicts survival time in ALS. Neurology 2006; 66: 265&#x2013;267.</Citation><ArticleIdList><ArticleId IdType="pubmed">16434671</ArticleId></ArticleIdList></Reference><Reference><Citation>Awisus F. TMS and threshold hunting. Suppl Clin Neurophysiol 2003; 56: 13&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">14677378</ArticleId></ArticleIdList></Reference><Reference><Citation>Niewiadomska M, Wochnik&#x2010;Dyjas D, Glazowski C. Cortical excitability threshold for distal limb muscles in transcranial magnetic stimulation. Method&#x2013;normative values. Neurobiol Exp (Wars) 1998; 58: 69&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">9583190</ArticleId></ArticleIdList></Reference><Reference><Citation>Amassian V, Stewart M, Quirk GJ, Rosenthal JL. Physiological basis of motor effects of a transient stimulus to cerebral cortex. Neurosurgery 1987; 20: 74&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">3543727</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanette G, Tamburin S, Manganotti P, Refatti N, Forgione A, Rizzuto N. Different mechanisms contribute to motor cortex hyperexcitability in amyotrophic lateral sclerosis. Clin Neurophysiol 2002; 113: 1688&#x2013;1697.</Citation><ArticleIdList><ArticleId IdType="pubmed">12417221</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierrot&#x2010;Deseilligny E, Burke D. The circuitry of the human spinal cord: spinal and corticospinal mechanisms of movement. New York, NY: Cambridge University Press, 2012.</Citation></Reference><Reference><Citation>Turner M, Kiernan M. Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis? Amyotroph Lateral Scler 2012; 13: 245&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pubmed">22424125</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M, Brockington A, Scaber J, et al Pattern of spread and prognosis in lower&#x2010;limb onset ALS. Amyotroph Lateral Scler 2010; 11: 369&#x2013;373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3182546</ArticleId><ArticleId IdType="pubmed">20001488</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J, La Spada A. ALS motor phenotype heterogeneity, focality and spread. Neurology 2009; 73: 805&#x2013;811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2739608</ArticleId><ArticleId IdType="pubmed">19738176</ArticleId></ArticleIdList></Reference><Reference><Citation>Walhout R, Verstraete E, Van den Heuvel MP, Veldink JH, Van den Berg LH. Patterns of symptom development in patients with motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener 2018; 19: 21&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">29037065</ArticleId></ArticleIdList></Reference><Reference><Citation>Dharmadasa T, Henderson R, Talman PS, et al Motor neuron disease: progress and challenges. Med J Aust 2017; 206: 357&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pubmed">28446118</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>